Trial Information
Generic NameTopiramateProduct NameTOPAMAX®Therapeutic AreaNervous System DiseasesEnrollment80% Female43.7%% White85%
Product ClassAnticonvulsantsSponsor Protocol NumberYTCData PartnerJohnson & JohnsonCondition StudiedEpilepsyMean/Median Age (Years)26.2
Supporting Documentation
- Collected Datasets Available
- Clinical Study Report Available